SNDL Inc.
SNDL evidence brief
What we can confirm
What it means
What to watch
Prepared research question
What matters most for SNDL—catalysts, financial risk and supporting evidence?
Traceable citations · Unknowns marked
BioSniper Score
Based on 2 of 6 signals
Limited data coverage
Market Cap
$369.6M
Cash Runway
—
Lead Asset
—
Next Catalyst
—
Financial data as of Dec 31, 2025.
Run SNDL Inc. through your own thesis
Use the pipeline, catalyst, financial, FDA, and market facts on this page as inputs to a protocol you control.
Your protocol can:
- Turn available SNDL Inc. facts into screen rules or deeper checks
- Show cited findings, blockers, and unresolved evidence together
- Save the logic and rerun it as the company evidence changes
Score breakdownBased on 2 of 6 signals · derived from public data
No clinical pipeline tracked — this score reflects financial & catalyst signals only.
Profitable (positive operating cash flow)
D/E 0.21
No tracked pipeline phase
No tracked pipeline candidates
No upcoming catalysts tracked
No insider transactions in the last 180 days
Financials
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
106
Total value held
$64.0M
| Holder | Shares | Value |
|---|---|---|
| morgan stanley | 11,411,121 | $15.1M |
| cannell capital llc | 8,761,155 | $11.6M |
| susquehanna international group, llp | 3,854,921 | $5.1M |
| advisorshares investments llc | 3,509,861 | $4.6M |
| arrowstreet capital, limited partnership | 2,996,423 | $4.0M |
| citadel advisors llc | 2,862,612 | $3.8M |
| mirae asset global etfs holdings ltd. | 2,239,364 | $3.0M |
| goldman sachs group inc | 1,182,075 | $1.6M |
| lazard asset management llc | 1,050,278 | $1.4M |
| man group plc | 828,494 | $1.1M |
Showing top 10 of 106 institutional holders of SNDL Inc.. Open the full 13F history after sign-in.
Short Interest
as of May 22, 2026- % of float
- 0.8%
- Days to cover
- 0.8
- Shares short
- 2,116,489
- Daily short volume
- -
Short percent of float and days-to-cover reflect reported short positioning. Daily short volume is the exchange-reported short share of a single day's trading volume and is noisier. See the most-shorted biotech ranking →
SNDL short interestFrequently asked questions
Who is the CEO of SNDL Inc.?
Mr. Zachary Ryan George IV is the chief executive officer of SNDL Inc. (SNDL).
Where is SNDL Inc. headquartered?
SNDL Inc. (SNDL) is headquartered in Edmonton, AB, Canada.
The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.